To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Partners sells majority stake in PCI Pharma to Kohlberg & Co; Blackstone snaps up Takeda’s Japanese consumer health unit; Branford strikes first Fund 2 investment
Takeda Pharmaceutical is divesting its Japanese consumer healthcare business to Blackstone Group and Branford Castle Partners buys Fibrix Filtration.
